PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-41.09%
Revenue decline while VET shows 6.72% growth. Joel Greenblatt would examine competitive position erosion.
17.49%
Cost growth above 1.5x VET's 3.40%. Michael Burry would check for structural cost disadvantages.
-74.47%
Gross profit decline while VET shows 8.18% growth. Joel Greenblatt would examine competitive position.
-56.66%
Margin decline while VET shows 1.36% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
10.73%
G&A growth less than half of VET's 32.00%. David Dodd would verify if efficiency advantage is structural.
No Data
No Data available this quarter, please select a different quarter.
4216.67%
Other expenses growth while VET reduces costs. John Neff would investigate differences.
8.61%
Similar operating expenses growth to VET's 9.56%. Walter Schloss would investigate norms.
14.29%
Total costs growth above 1.5x VET's 5.90%. Michael Burry would check for inefficiency.
-3.90%
Both companies reducing interest expense. Martin Whitman would check industry trends.
-3.58%
Both companies reducing D&A. Martin Whitman would check industry patterns.
-94.42%
Both companies show EBITDA decline. Martin Whitman would check industry conditions.
-91.13%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-112.04%
Operating income decline while VET shows 6.20% growth. Joel Greenblatt would examine position.
-120.44%
Both companies show margin pressure. Martin Whitman would check industry conditions.
26.98%
Other expenses growth while VET reduces costs. John Neff would investigate differences.
-117.80%
Both companies show declining income. Martin Whitman would check industry conditions.
-130.22%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-150.00%
Both companies reducing tax expense. Martin Whitman would check patterns.
-117.41%
Both companies show declining income. Martin Whitman would check industry conditions.
-129.56%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-117.74%
Both companies show declining EPS. Martin Whitman would check industry conditions.
-117.74%
Both companies show declining diluted EPS. Martin Whitman would check industry conditions.
-0.81%
Share count reduction while VET shows 0.26% change. Joel Greenblatt would examine strategy.
-1.42%
Diluted share reduction while VET shows 3.94% change. Joel Greenblatt would examine strategy.